Stockhub

ABIVAX Société Anonyme: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 08:5408:54, 16 August 2022 >Paris 1,096 bytes +1,096 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for..."
Retrieved from "https://stockhub.co/research/ABIVAX_Société_Anonyme"